Canada Pension Plan Investment Board
CCCC icon

Canada Pension Plan Investment Board’s C4 Therapeutics CCCC Stock Holding History

Canada Pension Plan Investment Board’s Portfolio CCCC Stock Details CCCC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$474K Sell
101,500
-34,100
-25% -$117K ﹤0.01% 1280
2026
Q1 		$357K Buy
135,600
+106,100
+360% +$250K ﹤0.01% 1353
2025
Q4 		$56.3K Buy
+29,500
New +$69.9K ﹤0.01% 1881

Other funds holding CCCC

Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
LCM
Lynx1 Capital Management San Juan, Puerto Rico $866M AUM 231.68% 1-Year Est. Return
SCM
Squadron Capital Management Westmont, Illinois $322M AUM
BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.68B AUM 126.09% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Canada Pension Plan Investment Board's CCCC Position: Q2 2026 in Review

Canada Pension Plan Investment Board reduced its C4 Therapeutics (CCCC) stake by 25% in Q2 2026, selling an estimated $117K and leaving 101,500 shares worth $474K. The position accounts for ﹤0.01% of the portfolio, ranked #1280.

Canada Pension Plan Investment Board first reported a position in CCCC in Q4 2025 and has held it in 3 quarters since. 147 funds tracked by Wall St. Rank hold CCCC as of Q2 2026.

  • Canada Pension Plan Investment Board held 101,500 shares of C4 Therapeutics worth $474K as of Q2 2026.
  • Canada Pension Plan Investment Board sold 34,100 C4 Therapeutics shares in Q2 2026, an estimated $117K.
  • C4 Therapeutics made up ﹤0.01% of Canada Pension Plan Investment Board's portfolio in Q2 2026, its #1280 holding.
  • Canada Pension Plan Investment Board first reported a position in C4 Therapeutics in Q4 2025 and has held it in 3 quarters since.
  • 147 funds tracked by Wall St. Rank held C4 Therapeutics as of Q2 2026.

Based on Canada Pension Plan Investment Board's 13F filing for Q2 2026, filed 14 Aug 2026.